ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 142 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,269,716 | +30.1% | 113,672 | +149.3% | 0.00% | -25.0% |
| Q2 2023 | $975,754 | +54.1% | 45,596 | +191.3% | 0.00% | +33.3% |
| Q1 2023 | $633,048 | -41.8% | 15,654 | -33.1% | 0.00% | -50.0% |
| Q4 2022 | $1,088,382 | -39.5% | 23,396 | -32.6% | 0.01% | -45.5% |
| Q3 2022 | $1,800,000 | +620.0% | 34,699 | +556.6% | 0.01% | +450.0% |
| Q2 2022 | $250,000 | -62.2% | 5,285 | -43.2% | 0.00% | -66.7% |
| Q1 2022 | $662,000 | +4.4% | 9,303 | +9.7% | 0.01% | +20.0% |
| Q4 2021 | $634,000 | +26.8% | 8,479 | +4.7% | 0.01% | -68.8% |
| Q4 2019 | $500,000 | – | 8,096 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |